HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Apraclonidine

HCID 2216
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
66711-21-5
Standard SMILES
Nc1cc(Cl)c(NC2=NCCN2)c(Cl)c1
InChIKey
IEJXVRYNEISIKR-UHFFFAOYSA-N
Molecular formula
C9H10Cl2N4
Average molar mass
245.11 g/mol
Monoisotopic mass
244.0282517

Overview

Apraclonidine is an imidazoline that is 2-amino 4,5-dihydro-1H-imidazoline in which one of the exocyclic amino hydrogens has been replaced by a 4-amino-2,6-dichlorophenyl group. It has a role as a diagnostic agent, a beta-adrenergic agonist, an alpha-adrenergic agonist, an antiglaucoma drug and an ophthalmology drug. It is a dichlorobenzene, a member of guanidines and a member of imidazolines. It is a conjugate base of an apraclonidine(1+).

Names & identifiers

Preferred name
Apraclonidine
IUPAC
2,6-dichloro-1-N-(4,5-dihydro-1H-imidazol-2-yl)benzene-1,4-diamine
English name
Apraclonidine
Molecular formula
C9H10Cl2N4
Molecular weight
245.11

Names & synonyms

apraclonidine66711-21-54-AminoclonidineApraclonidinaApraclonidinump-aminoclonidine2,6-dichloro-1-N-(4,5-dihydro-1H-imidazol-2-yl)benzene-1,4-diamine843CEN85DICHEBI:2788DTXSID10484151,4-Benzenediamine, 2,6-dichloro-N'-(4,5-dihydro-1H-imidazol-2-yl)-para-aminoclonidine
Show more names
NC-14ApraclonldineApraclondine HclApraclonidine USP/EP/BPApraclonidine - API Standards2-((4-Amino-2,6-dichlorophenyl)imino)imidazolidine2,6-Dichloro-N-(4,5-dihydro-1H-imidazol-2-yl)benzene-1,4-diamine
Iopimax2-(4-amino-2,6-dichloro)phenyliminoimidazolidineRefChem:57693DTXCID9028388S01EA03AplonidineApraclonidinum [INN-Latin]Apraclonidina [INN-Spanish]

Database identifiers

CAS
66711-21-5

Properties

Computed structural properties

XLogP
1.3
Topological polar surface area
62.4 Ų
Hydrogen bond donors
3
Hydrogen bond acceptors
2
Rotatable bonds
2
Heavy atoms
15
Formal charge
0
Complexity
246

Experimental & physicochemical properties

DrugsPharmaceuticals -> Listed in ZINC15
LogP1.4
Solubility4.09e-01 g/L
Human DrugsBreast Feeding; Lactation; Adrenergic alpha-2 Receptor Agonists; Antiglaucoma Agents
Physical DescriptionSolid

Physicochemical properties

Melting point
230 ° · >230°
Boiling point
395.5 · 395.5±52.0 °C(Predicted)
Density
1.63 · 1.63±0.1 g/cm3(Predicted)
storage temp.
2 · Sealed in dry,2-8°C
solubility
45 % · 45% (w/v) aq 2-hydroxypropyl-β-cyclodextrin: 1.4 mg/mL Solutions may be stored for several days at 4°C
form
solid
pka
9.26 · 9.26±0.50(Predicted)

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Danger

H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]

P261, P262, P264, P270, P271, P280, P301+P316, P302+P352, P304+P340, P316, P321, P330, P361+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 38 reports by companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Hazard Classes and CategoriesAcute Tox. 3 (100%)

Toxicology

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

Safety data

wgk
3
ridadr
UN 2811 6.1/PG 1
risk_code
23/24/25
Signal word
Danger
Symbol(GHS)
GHS06
hazard_code
T
safety_code
22-36/37/39-45
Hazard statements
H311-H331-H301
Precautionary statements
P264-P270-P301+P310-P321-P330-P405-P501-P280-P302+P352-P312-P322-P361-P363-P405-P501-P261-P271-P304+P340-P311-P321-P403+P233-P405-P501

Chemistry & industry

Pharmacology

ATC Code · 3 items

S01EA03

S - Sensory organs

QS - Sensory organs

Protein Binding98.7%
PharmacodynamicsApraclonidine significantly lowers intraocular pressure with minimal effects on cardiovascular and pulmonary parameters. It lowers intraocular pressure by reducing aqueous humor production and increasing uveoscleral outflow.
Mechanism of Action · 1 item

Apraclonidine is a relatively selective alpha2 adrenergic receptor agonist that stimulates alpha1 receptors to a lesser extent. It has a peak ocular hypotensive effect occurring at two hours post-dosing. The exact mechanism of action is unknown, but fluorophotometric studies in animals and humans suggest that Apraclonidine has a dual mechanism of action by reducing aqueous humor production through the constriction of afferent ciliary process vessels, and increasing uveoscleral outflow.

Biological Half-Life8 hours
FDA Pharmacological Classification · 6 items

843CEN85DI

APRACLONIDINE

Mechanisms of Action [MoA] - Adrenergic alpha-Agonists

Established Pharmacologic Class [EPC] - alpha-Adrenergic Agonist

Apraclonidine is an alpha-Adrenergic Agonist. The mechanism of action of apraclonidine is as an Adrenergic alpha-Agonist.

APRACLONIDINE

MeSH Pharmacological ClassificationCompounds that bind to and activate ADRENERGIC ALPHA-2 RECEPTORS.
Absorption, Distribution and Excretion · 1 item

Topical use of apraclonidine ophthalmic solution leads to systemic absorption. Studies of apraclonidine (0.5% ophthalmic solution) dosed one drop three times a day in both eyes for 10 days in normal volunteers yielded mean peak and trough concentrations of 0.9 ng/mL and 0.5 ng/mL, respectively.

Related reactions

1 records
New reaction record
HRID 637716 reaction equation
HRID 637716As product

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
PubChem CID
2216
DTXSID
DTXSID1048415
ChEMBL
CHEMBL647
ChEBI
CHEBI:2788
UNII
843CEN85DI
EC Number
636-293-2
Nikkaji
J247.956G
color
white
CAS DataBase Reference
66711 · 66711-21-5(CAS DataBase Reference)
FDA UNII
843 CEN85DI · 843CEN85DI
ATC code
1 EA03 · S01EA03
Comptox DTXSID
1048415 · DTXSID1048415
Symbol(GHS)
6 · GHS06
Signal word
Danger
Hazard statements
311 · H311-H331-H301
Precautionary statements
264 · P264-P270-P301+P310-P321-P330-P405-P501-P280-P302+P352-P312-P322-P361-P363-P405-P501-P261-P271-P304+P340-P311-P321-P403+P233-P405-P501
Hazard Codes
T
Risk Statements
23 · 23/24/25
Safety Statements
22 · 22-36/37/39-45
RIDADR
2811 · UN 2811 6.1/PG 1
WGK Germany
3 · 3
Cellular LocationsMembrane
Applications · 1 item

General DescriptionIn addition to its therapeutic use as an antihypertensiveagent, clonidine has been found to provide beneficialeffects in several other situations, including glaucoma,spasticity, migraine prophylaxis, opiate withdrawal syndrome,and anesthesia. This has prompted the developmentof analogs of clonidine for specific use in some of the mentionedareas. Two of such examples are apraclonidine andbrimonidine. Apraclonidine does not cross the BBB.However, brimonidine can cross the BBB and hence canproduce hypotension and sedation, although these CNSeffects are slight compared with those of clonidine. CNS effectsof these drugs are correlated well to their log P, pKa,and thus log D value. Both apraclonidine and brimonidineare selective α2-agonists with α1: α2 ratios of 30:1 and1,000:1, respectively. Brimonidine is a much more selectiveα2-agonist than clonidine or apraclonidine and is a firstlineagent for treating glaucoma. Apraclonidines’s primarymechanism of action may be related to a reduction of aqueousformation, whereas brimonidine lowers intraocularpressure by reducing aqueous humor production and increasinguveoscleral outflow. Apraclonidine is used specificallyto control elevations in intraocular pressure that canoccur during laser surgery on the eye. Another example istizanidine (Zanaflex), which finds use in treating spasticityassociated with multiple sclerosis or spinal cord injury. Bystimulating 2-adrenergic receptors, it is believed to decreasethe release of excitatory amino acid NTs from spinalcord interneurons.

Upstream & downstream products

Upstream raw materials

TolueneEthylenediamineThiophosgeneAluminium-nickeltert-Butyl methyl etherHexaneIsopropyl alcoholMethanol

Downstream products

Apraclonidine hydrochloride

Additional notes

DefinitionChEBI: An imidazoline compound having a 4-amino-2,6-dichloroanilino group at the 2-position.